Longitudinal Observation by Optical Coherence Tomography in Patients Treated with Ethambutol: A Systematic Review and Meta-Analysis
Open Access
- 4 February 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1230
Abstract
Background: The retinal changes caused by ethambutol are not clear in patients with the administration of ethambutol and without ethambutol-induced optic neuropathy (EON). The aim of this systematic review is to estimate the changes in retinal nerve fiber layer (RNFL) and ganglion cell layer and inner plexiform layer (GCIPL) thicknesses measured by optical coherence tomography (OCT) in patients with mycobacterial infection treated with ethambutol and not suffering from EON. Methods: A systematic review of articles was conducted by searching PubMed, Embase, and Web of Science until November 2025. Additional studies were identified by the review of references. Search terms included OCT and ethambutol. Longitudinal observational studies using an OCT device to measure RNFL and GCIPL thicknesses before and after the administration of ethambutol in patients with mycobacterial infection without ocular diseases were included. The extraction of data in studies was performed by two researchers using data extraction sheets. The meta-analysis was conducted using the random-effect model. Results: In total, 14 studies (n = 1138) were eligible for the systematic review. Meta-analysis combining RNFL measured after the longest duration of ethambutol administration showed no significant decrease compared to RNFL before treatment. However, there were significant decreases in RNFL thickness in male-dominant studies, studies conducted in Turkey and India, and studies conducted by the Cirrus OCT device. In addition, the decreases in RNFL thickness were correlated with the duration of ethambutol administration in male-dominant studies. Only two studies reported the thickness changes in GCIPL, and the study with a higher male proportion showed significant decreases in GCIPL thickness. Conclusions: Ethambutol does not cause a significant RNFL decrease generally in mycobacterial infection patients; however, it may lead to decreased RNFL thickness in male patients and patients in some regions, even though they do not suffer from EON.Keywords
Funding Information
- National High Level Hospital Clinical Research Funding (2022-PUMCH-B-103)
This publication has 61 references indexed in Scilit:
- Programmatic Assessment of Ethambutol-Related Optic Neuropathy in Patients with Mycobacterial Infections: A Prospective Observational Cohort StudyInfectious Diseases and Therapy, 2025
- Optical coherence tomography and angiography in multiple sclerosis: A systematic review and meta-analysisJournal of the Neurological Sciences, 2025
- Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Quality of Life Research, 2024
- Ocular Toxicity of Ethambutol During Both Intensive and Continuation Phases of Anti-Tubercular Therapy in ChildrenIndian Pediatrics, 2022
- Demographics of a Large International Population of Patients Affected by Leber’s Hereditary Optic NeuropathyOphthalmology, 2020
- Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegenerationJournal of Controlled Release, 2020
- Data On Smoking In Turkey: Systematic Review, Meta-Analysis And Meta-Regression Of Epidemiological Studies On Cardiovascular Risk FactorsAtherosclerosis, 2019
- Longitudinal analysis of retinal nerve fiber layer and ganglion cell–inner plexiform layer thickness in ethambutol-induced optic neuropathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2015
- RIFAMPICIN: An antibiotic with brain protective functionBrain Research Bulletin, 2014
- Bilateral optic neuritis due to isoniazid (INH)Indian Pediatrics, 2010